MWG Caph Ltd
Sector Allocation
- Healthcare100.0%$72.4M
Largest positions — Q4 2025
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/mwg-caph-ltd-2111120
MWG Caph Ltd 13F holdings — Q4 2025
$72.4M portfolio · 3 holdings · Q4 2025 13F · top 10 are 100% of the stock portfolio
$35.1M
48.5% of stocks
—This quarter-24.2%Since Q-end1+ qtrsHeld$31.0M
42.9% of stocks
—This quarter-54.9%Since Q-end1+ qtrsHeld$6.2M
8.6% of stocks
—This quarter+10.1%Since Q-end1+ qtrsHeld
| # | Company | Value | Weight | This quarter | Since Q-end | Held | AI quality | Est. buy | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | $35.1M | 48.5% | — | -24.2% | 1+ qtrs | 35.0#2,319 | Estimated buy price is Pro: unlock with a free trial | ||
| 2 | $31.0M | 42.9% | — | -54.9% | 1+ qtrs | 11.9#2,867 | Estimated buy price is Pro: unlock with a free trial | ||
| 3 | $6.2M | 8.6% | — | +10.1% | 1+ qtrs | 31.6#2,450 | Estimated buy price is Pro: unlock with a free trial |
Is it too late to follow MWG Caph Ltd?
Holdings as of Dec 31, 2025 (SEC filing). Prices are closing prices as of Nov 18, 2026.
Average quality of MWG Caph Ltd's top 20 holdings: 25/100 (our AI quality score, weighted by position size; 3 of the 20 are scored)
Top 10 since quarter-end
-34.4%
Value-weighted move of the 10 largest stock positions
Turnover
—
Last quarter
Top 10 weight
100%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
0%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 3 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
MWG Caph Ltd disclosed 3 positions worth $72.4M in its Form 13F-HR for Q4 2025, led by $BEAM (Beam Therapeutics Inc.) at 48.5% of the equity portfolio, followed by $LYEL and $PRME. During the quarter the fund opened 3 new positions and exited 0 — including a new stake in $BEAM. The portfolio is most concentrated in Healthcare (100.0% of disclosed assets). All figures are sourced directly from MWG Caph Ltd’s Form 13F-HR filing with the SEC under CIK 2111120.
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: MWG Caph Ltd
13F Pro is an AI hedge fund tracker and stock research platform. For MWG Caph Ltd (SEC CIK: 2111120), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in MWG Caph Ltd's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.